Antifungal Drugs: Special Problems Treating Central Nervous System Infections
Treating fungal infections in the central nervous system (CNS) remains a challenge despite the availability of new antifungal agents. Therapy is limited by poor understanding of the kinetic properties of antifungal drugs in the CNS compounded by lack of data for many agents. In some cases, clinical...
Main Author: | Elizabeth Dodds Ashley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/5/4/97 |
Similar Items
-
AIDS-associated Talaromyces marneffei central nervous system infection in patients of southwestern China
by: Yu-Ye Li, et al.
Published: (2020-05-01) -
Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report
by: Hui Zhao, et al.
Published: (2019-05-01) -
Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
by: Xuzhao Zhang, et al.
Published: (2021-07-01) -
Central Nervous System Infections in Children
by: Mustafa Taşkesen, et al.
Published: (2007-01-01) -
Candida Infection of Central Nervous System
by: Ali MERT
Published: (2008-12-01)